Skip to content
Disclosery

Hillview Capital Advisors, LLC

Follow

13F filer, CIK 1631615, Wayne, PA

Hillview Capital Advisors, LLC reported $25,866,000 across 5 holdings for the quarter ended 2018-09-30, in a 13F-HR filed 2018-10-23.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-18-001881

Period
2018-09-30
Reported value
$25.9M
Holdings
5
Top 10 weight
100%
New
3
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AMZNnew+113$226K
VIGnew+1,919$213K
INNOVATE BIOPHARMACEUTICLS Inew+19,610$134K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VTIexited-2,583-$363K
VEAreduced-3,884-$168K
VTreduced-134-$10.2K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2018

Share positions as resolved from 13F-HR 0001172661-18-001881, largest first. % of portfolio is the value over $25,866,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VEAVANGUARD TAX-MANAGED FDSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: 359,298 shares; 2017Q4: 359,704 shares; 2018Q1: 449,249 shares; 2018Q2: 453,506 shares; 2018Q3: 449,622 shares 449,622$19.5M75.21%-3,884Timeline
VTVANGUARD INTL EQUITY INDEX FQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: 90,362 shares; 2017Q4: 88,009 shares; 2018Q1: 77,638 shares; 2018Q2: 77,117 shares; 2018Q3: 76,983 shares 76,983$5.84M22.57%-134Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: not reported; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 113 shares 113$226K0.87%newTimeline
VIGVANGUARD SPECIALIZED FUNDSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: not reported; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 1,919 shares 1,919$213K0.82%newTimeline
INNOVATE BIOPHARMACEUTICLS IINNOVATE BIOPHARMACEUTICLS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: not reported; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 19,610 shares 19,610$134K0.52%new

Sold out in Q3 2018

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VTIVANGUARD INDEX FDS2,583$363Kshares

How Q3 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-18-001881 base2018-10-23acceptance time not in the bulk data set